Reply to: Comment on Cross-over to Photodynamic Therapy or Micropulse Laser After Failure of Primary Treatment of Chronic Central Serous Chorioretinopathy

We thank the authors for their interest regarding our studies on chronic central serous chorioretinopathy (cCSC), including the PLACE trial and the REPLACE trial.1,2(+ reference to Correspondence, Wu and Roca, AJO, 2020)

Source: American Journal of Ophthalmology - November 11, 2020 Category: Opthalmology Authors: Thomas J. van Rijssen, Elon H.C. van Dijk, Paula Scholz, Myrte B. Breukink, Greet Dijkman, Petrus J.H. Peters, Roula Tsonaka, Robert E. MacLaren, Susan M. Downes, Sascha Fauser, Camiel J.F. Boon, Carel B. Hoyng Tags: Correspondence Source Type: research